Fewer gastrointestinal events with vutrisiran versus placebo in patients with transthyretin amyloidosis with cardiomyopathy: analysis from the phase 3 HELIOS-B study

Amyloid · Published 2026-07-17 · DOI 10.1080/13506129.2026.2695367

Free full text

Authors (11)

Marcus A. Urey, Quan M. Bui, Laura Obici, Jonas Wixner, Erwan Donal, Hiroaki Kitaoka, Ainara Lozano-Bahamonde, Shaun Bender, Katherine L. Boyle, Emre Aldinc, Caroline Morbach

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Urey, M., Bui, Q., Obici, L., et al. (2026). Fewer gastrointestinal events with vutrisiran versus placebo in patients with transthyretin amyloidosis with cardiomyopathy: analysis from the phase 3 HELIOS-B study. Amyloid. https://doi.org/10.1080/13506129.2026.2695367

Related articles

• ALyzer3D.AI: a more generalizable deep learning predictor of light chain amyloidogenicity powered by structural and evolutionary Artificial Intelligence · Amyloid · 2025 · Same journal
• Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension · Amyloid · 2026 · Same journal
• Limited diagnostic utility of systematic Congo red staining in bone marrow biopsies · Amyloid · 2025 · Same journal
• Clinical profile and outcome of AA amyloidosis associated kidney disease in India · Amyloid · 2025 · Same journal
• Medin and transthyretin: a new amyloid double act in the aortic wall and valves · Amyloid · 2025 · Same journal
• Clinical and radiological stabilization following vutrisiran treatment in transthyretin leptomeningeal amyloidosis: a case report · Amyloid · 2025 · Same journal
• Clinical significance of gastric food residue in gastrointestinal hereditary transthyretin amyloidosis · Amyloid · 2026 · Same journal
• Proline-rich, polybasic peptides are a structurally distinct class of amyloid-reactive peptides · Amyloid · 2026 · Same journal
• Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain Amyloidosis · Amyloid · 2025 · Same journal
• Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients · Amyloid · 2025 · Same journal